INDV Indivior plc: Net earnings per share growth forecast for next year

indivior.com (INDV) - corporate logo

The addiction treatment sector adheres to environmental standards during pharmaceutical production. Indivior PLC is implementing long-acting therapy technologies to save lives. Stringent FDA oversight and patents create an insurmountable barrier to entry for competitors. The consensus on next year's earnings per share changes demonstrates analyst expectations, where 25.20 reflects the latest value of the metric.

INDV: Indivior plc Projected earnings per share growth rate for next year 02/21/2024 - 11/12/2026
Brand item of indivior.com

This indicator measures the analysts' consensus forecast for the change in earnings per share (EPS) for the coming year, allowing for the rapid capture of revisions to the asset's fundamental value following earnings reports. The growth of this valuation regarding future EPS dynamics confirms the effectiveness of the Sublocade expansion for Indivior PLC (INDV), signaling to investors a transition from the stage of settling legacy lawsuits to a phase of active commercial sales scaling.

Competitors of Indivior PLC

COLL (Collegium Pharmaceutical Inc) - Earnings growth forecast for next year|Cronos Corp (CRON) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Canopy Growth (CGC)|hightideinc.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year ACB (Aurora Cannabis Inc.)|ACHV: Projected earnings per share growth rate for next year|Skye Bioscience - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Anebulo Pharma ANEB|INCR (intercure.co) - Expected earnings per share growth for next year|NTRB (Nutriband) - Net earnings per share growth forecast for next year|NSRX (Nasus Pharma Ltd.) - Earnings growth forecast for next year|IGC Pharma Inc (IGC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year MIRA Pharmaceuticals (MIRA)|FLGC - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year IM Cannabis IMCC|Expected earnings per share trend next year ADIL|ARTL: Expected earnings per share growth for next year|Expected earnings per share trend next year ENSC (Ensysce Biosciences)|titanpharm.com (TTNP) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year GNLN (Greenlane Corp)|Net earnings per share growth forecast for next year InMed Pharmaceuticals|Net earnings per share growth forecast for next year AKAN|Earnings growth forecast for next year ENVB|Expected earnings per share growth for next year brightgreen.us BGXX|Earnings growth forecast for next year HPCO (Hempacco Co., Inc.)